Effects of functionally distinct dietary fibers in starch-containing meals on medium-chain triglyceride (MCT)-induced ketone body synthesis

FH Münster0 个研究点目标入组 15 人开始时间: 2026年10月26日最近更新: 2026年8月3日

适应症

试验速览

暂无简介。

•Pregnancy, breastfeeding
•Presence of a serious or chronic condition causing significant health impairments (e.g. cancer, cardiovascular disease, thyroid disorders, bowel diseases) or an acute illness at the time of the examination
•Known metabolic disorder (e.g. lipid metabolism disorder, type 1 or 2 diabetes mellitus)
•Taking medication (exception: contraceptives)
•Consumption of MCT within the past 4 weeks
•Mental or speech impairments
•Low-carb or other dietary regimens involving a sustained reduction in carbohydrate intake (EFSA: at least 45% of energy from carbohydrates)
•Diagnosed eating disorders
•Known swallowing disorders or conditions involving clinically significant dysphagia or an increased risk of aspiration
•Donation of whole blood within the last 3 months and/or donation of blood plasma within the last 4 weeks prior to the start of the study
•Intolerance to sucralose or other sweeteners
•Difficult or impossible venous blood sampling due to anatomical conditions or other medical reasons (e.g. veins that are difficult to locate, fragile or severely sclerosed)
•Severe fear of blood sampling or injections
•Functional bowel disorders (particularly irritable bowel syndrome), lactose intolerance, milk protein allergy

发起方